Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020096340 - PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES

Publication Number WO/2020/096340
Publication Date 14.05.2020
International Application No. PCT/KR2019/014960
International Filing Date 06.11.2019
IPC
A61K 35/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K 35/545
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
48Reproductive organs
54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
A61K 31/215 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
A61P 37/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
06Immunosuppressants, e.g. drugs for graft rejection
C12N 5/0775 2010.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
071Vertebrate cells or tissues, e.g. human cells or tissues
077Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
0775Mesenchymal stem cells; Adipose-tissue derived stem cells
Applicants
  • 코아스템(주) CORESTEM CO.,LTD. [KR]/[KR]
Inventors
  • 김경숙 KIM, Kyung Suk
  • 이태용 LEE, Tae Yong
Agents
  • 특허법인 이룸리온 ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM
Priority Data
10-2018-013757809.11.2018KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT DES CELLULES SOUCHES TRAITÉES PAR UN ACTIVATEUR DE PROTÉINE KINASE C OU UNE CULTURE DE CELLES-CI POUR PRÉVENIR OU TRAITER DES MALADIES AUTO-IMMUNES
(KO) 단백질 키나아제 C 활성화제로 처리된 줄기세포 또는 그 배양물을 포함하는 자가면역질환 예방 또는 치료용 약학적 조성물
Abstract
(EN)
The present invention relates to a pharmaceutical composition containing protein kinase C activator-treated stem cells or a culture thereof for preventing or treating autoimmune diseases, more specifically to a pharmaceutical composition which can inhibit B-cell function to thus be superbly effective in preventing or treating autoimmune diseases.
(FR)
La présente invention concerne une composition pharmaceutique contenant des cellules souches traitées par un activateur de protéine kinase C ou une culture de celles-ci pour prévenir ou traiter des maladies auto-immunes, plus particulièrement une composition pharmaceutique qui peut inhiber la fonction des lymphocytes B pour ainsi être extrêmement efficace dans la prévention ou le traitement de maladies auto-immunes.
(KO)
본 발명은 단백질 키나아제 C 활성화제(protein kinase C activator)로 처리된 줄기세포 또는 그 배양물을 포함하는 자가면역질환 예방 또는 치료용 약학적 조성물에 관한 것으로, 더욱 상세하게는 B 세포의 기능을 억제할 수 있어 자가면역질환의 예방 또는 치료 효과가 우수한, 자가면역질환 예방 또는 치료용 약학적 조성물에 관한 것이다.
Latest bibliographic data on file with the International Bureau